CME Symposium- Managing LDL-C with PCSK9 Inhibitors: Identifying the Patients, Optimizing the Outcomes

This CME Symposium takes place on Friday, February 22, 2019, from 6:45 PM- 9:00 PM at the Hilton Portland Downtown, Galleria Ballroom, 921 SW Sixth Avenue, Portland, Oregon.
By: Voxmedia LLC
2019 NLA Spring Clinical Update CME Symposium
2019 NLA Spring Clinical Update CME Symposium
SPRINGFIELD, N.J. - Jan. 16, 2019 - PRLog -- Register Online Now
LDL-cholesterol (LDL-C) is a central focus of cardiovascular risk reduction. Prudent use of PCSK9 inhibitors requires the identification of patients with elevated LDL-C at increased cardiovascular risk. High-risk patients include those with atherosclerotic cardiovascular disease (ASCVD) and those with LDL-C ≥ 190 mg/dL without ASCVD. Awareness of the evidence with PCSK9 inhibitors, discussions of best use of these agents by lipid experts, and interactive case presentations aim to facilitate treatment by lipidologists of appropriate patients with these drugs to optimize clinical outcomes. In this program, Chair Dr. James Underberg, and faculty members Dr. Ty Gluckman, Dr. Margo Minissian, Dr. Michael Shapiro, and Dr. Pam Taub, will use these educational formats to assist lipidologists in patient management with PCSK9 inhibitors.

James Underberg, MD, MS
Clinical Assistant Professor of Medicine
New York University School of Medicine
New York, New York

Ty Gluckman, MD
Medical Director, Center for Cardiovascular
Analytics, Research, and Data Science
Providence Heart Institute
Providence St. Joseph Health
Portland, Oregon

Margo Minissian, PhD, ACNP, CLS, AACC
Nurse Scientist, Cardiology Nurse Practitioner
Barbra Streisand Women's Heart Center
Smidt Heart Institute
Cedars-Sinai Medical Center
Los Angeles, California

Michael Shapiro, DO
Associate Professor of Medicine and Radiology
Oregon Health & Science University
Portland, Oregon

Pam Taub, MD
Associate Professor of Medicine
University of California San Diego
La Jolla, California

The National Lipid Association and Voxmedia International gratefully acknowledges the educational grant supported by Amgen.

This activity is designed to meet the needs of lipidologists, internists, endocrinologists, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses and registered dietitians with an interest in lipid management.

Pre-registration is for planning purposes only.

For additional CME activities and online cme courses visit CMEPlanet

Email:*** Email Verified
Tags:Cme, Nla, Spring Clinical Update, Ldl, Cholesterol, PCSK9
Industry:Education, Event, Medical
Location:Springfield - New Jersey - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse

Like PRLog?
Click to Share